Palvella Therapeutics (PVLA) Return on Equity: 2015-2024
Historic Return on Equity for Palvella Therapeutics (PVLA) over the last 10 years, with Sep 2024 value amounting to -0.00%.
- Palvella Therapeutics' Return on Equity rose 98.00% to -0.00% in Q3 2024 from the same period last year, while for Sep 2024 it was -0.00%, marking a year-over-year increase of 98.00%. This contributed to the annual value of -0.80% for FY2023, which is 28.00% up from last year.
- Palvella Therapeutics' Return on Equity amounted to -0.00% in Q3 2024, which was down 108.14% from 0.05% recorded in Q2 2024.
- Palvella Therapeutics' Return on Equity's 5-year high stood at 0.46% during Q4 2023, with a 5-year trough of -2.33% in Q1 2023.
- For the 3-year period, Palvella Therapeutics' Return on Equity averaged around -0.78%, with its median value being -1.02% (2022).
- As far as peak fluctuations go, Palvella Therapeutics' Return on Equity tumbled by 128bps in 2023, and later surged by 229bps in 2024.
- Palvella Therapeutics' Return on Equity (Quarterly) stood at -0.89% in 2020, then declined by 10bps to -0.99% in 2021, then crashed by 35bps to -1.34% in 2022, then surged by 180bps to 0.46% in 2023, then skyrocketed by 98bps to -0.00% in 2024.
- Its last three reported values are -0.00% in Q3 2024, 0.05% for Q2 2024, and -0.03% during Q1 2024.